Biological Sciences Division
Published August 3, 2017 | Version v1
Patent Open

MODULATION OF LAMININ ALPHA-4 IN THE PREVENTION, TREATMENT, AND MANAGEMENT OF METABOLIC SYNDROMES

Creators

  • 1. Illinois Institute of Technology
  • 2. University of Chicago
  • 3. Karolinska Institutet

Contributors

Description

The disclosure provides methods of preventing or treating metabolic syndrome in a subject by administering an effective amount of an inhibitor of laminin α4 expression, laminin α4 activity, or both.

Files

US20170216409.pdf

Files (1.1 MB)

Name Size Download all
md5:bff2124294a2e6465530b010f60f5c4a
1.1 MB Preview Download

Additional details

Identifiers

Patent application number
US 201515500845 A
Patent number
US 2017/0216409 A1
Other
oai:uchicago.tind.io:9537

Dates

Patent filed
2015-08-05

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Molecular Metabolism and Nutrition, Medicine